Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+


  Urinary Tract Infection, April 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 122 articles:
HTML format


 

Single Articles

  1. O'KEEFE LC, Koelle P, McGee Z, Dewberry LS, et al
    Innovations in Worksite Diagnosis of Urinary Tract Infections and the Occupational Health Nurse.
    Workplace Health Saf. 2019 Mar 29:2165079919834310.
    Abstract    

    Abstract available

  2. FANCHIANG YC, Yen YH, Chen SW
    [Using Nursing Digital Technology to Reduce the Rates of Catheter-Associated and Non-Catheter-Associated Urinary Tract Infection].
    Hu Li Za Zhi. 2019;66:77-84.
    Abstract    

    Abstract available

  3. NICOLLE L
    Symptomatic urinary tract infection or asymptomatic bacteriuria? Improving Care for the Elderly.
    Clin Microbiol Infect. 2019 Mar 25. pii: S1198-743X(19)30115.
    Abstract    



  4. ALOUSH SM, Al Qadire M, Assmairan K, Al Sheikh H, et al
    Risk factors for hospital-acquired non-catheter-associated urinary tract infection.
    J Am Assoc Nurse Pract. 2019 Mar 22. doi: 10.1097/JXX.0000000000000175.
    Abstract    

    Abstract available

  5. LOPEZ-MARTIN L, Alcover-Diaz J, Charry-Gonima P, Gonzalez-Lopez R, et al
    Prospective Observational Cohort Study of the Efficacy of Bacterial Immune Prophylaxis in the Prevention of Uncomplicated, Recurrent Urinary Tract Infections.
    Urol Int. 2019 Mar 27:1-7. doi: 10.1159/000497107.
    Abstract    

    Abstract available

  6. DIMITROVA NI, Gasretova TD, Alutina EL, Kharseeva GG, et al
    [Sensitivity and resistance to antimicrobial agents ESBL-producing and not producing ESBL strains of E. coli in patients with urinary tract infection.]
    Klin Lab Diagn. 2019;64:104-110.
    Abstract    

    Abstract available

  7. ADVANI SD, Fakih MG
    The evolution of catheter-associated urinary tract infection (CAUTI): Is it time for more inclusive metrics?
    Infect Control Hosp Epidemiol. 2019 Mar 27:1-5. doi: 10.1017/ice.2019.
    Abstract    

    Abstract available

  8. KOHADA Y, Goriki A, Yukihiro K, Ohara S, et al
    The risk factors of urinary tract infection after transurethral resection of bladder tumors.
    World J Urol. 2019 Mar 26. pii: 10.1007/s00345-019-02737.
    Abstract    

    Abstract available

  9. PATEL HB, Soni ST, Bhagyalaxmi A, Patel NM, et al
    Causative agents of urinary tract infections and their antimicrobial susceptibility patterns at a referral center in Western India: An audit to help clinicians prevent antibiotic misuse.
    J Family Med Prim Care. 2019;8:154-159.
    Abstract    

    Abstract available

  10. BISTA B, Champion JD
    Does treatment of urinary tract infections reflect the antibiotic stewardship program guidelines?
    J Am Assoc Nurse Pract. 2019 Mar 21. doi: 10.1097/JXX.0000000000000204.
    Abstract    

    Abstract available

  11. ODOKI M, Almustapha Aliero A, Tibyangye J, Nyabayo Maniga J, et al
    Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda.
    Int J Microbiol. 2019;2019:4246780.
    Abstract    

    Abstract available

  12. FORSTER CS, Haffey WD, Bennett M, Greis KD, et al
    Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders.
    Biomark Insights. 2019;14:1177271919835570.
    Abstract    

    Abstract available

  13. THARWAT N, El-Sherif R, Elnagdy S, Marzaban R, et al
    Virulent Escherichia coli strains among Egyptian patients with acute diarrhoea versus urinary tract infection, and their antibiotic susceptibility.
    Arab J Gastroenterol. 2019 Mar 21. pii: S1687-1979(19)30004.
    Abstract    

    Abstract available

  14. HORSLEY H, Owen J, Carugo D, Malone-Lee J, et al
    Ultrasound-activated microbubbles as a novel intracellular drug delivery system for urinary tract infection.
    J Control Release. 2019 Mar 20. pii: S0168-3659(19)30166.
    Abstract    

    Abstract available

  15. HOSSEINI SS, Ghaemi E, Noroozi A, Niknejad F, et al
    Zinc Oxide Nanoparticles Inhibition of Initial Adhesion and ALS1 and ALS3 Gene Expression in Candida albicans Strains from Urinary Tract Infections.
    Mycopathologia. 2019 Mar 22. pii: 10.1007/s11046-019-00327.
    Abstract    

    Abstract available

  16. AHOUAH M, Lombrail P, Gavazzi G, Chaaban T, et al
    ATOUM 6: does a multimodal intervention involving nurses reduce the use of antibiotics in French nursing homes?: A protocol for a cluster randomized study.
    Medicine (Baltimore). 2019;98:e14734.
    Abstract    

    Abstract available

  17. FORSON AO, Tsidi WB, Nana-Adjei D, Quarchie MN, et al
    Escherichia coli bacteriuria in pregnant women in Ghana: antibiotic resistance patterns and virulence factors.
    BMC Res Notes. 2018;11:901.
    Abstract    

    Abstract available

  18. JACQUELINE C, Abbate JL, Sorci G, Guegan JF, et al
    The macroecology of cancer incidences in humans is associated with large-scale assemblages of endemic infections.
    Infect Genet Evol. 2018;61:189-196.
    Abstract    

    Abstract available

  19. ALAYGUT D, Engin A
    Pasteurella aerogenes as an Asymptomatic Bacteriuria Agent.
    J Trop Pediatr. 2018;64:82-84.
    Abstract    

    Abstract available

  20. CHANG MH, Lath N, Lim JF, Low ASC, et al
    Case of an adult tubular sigmoid duplication with associated vascular and urological abnormality.
    ANZ J Surg. 2018;88:E352-E354.
    Abstract    



  21. HU W, Xie S, Yu F, Hao W, et al
    Characteristics of pathogens and mortality predictors of older Chinese patients with nosocomial urinary tract infections.
    Geriatr Gerontol Int. 2019 Apr 5. doi: 10.1111/ggi.13661.
    Abstract    

    Abstract available

  22. BEN AYED H, Koubaa M, Hammami F, Marrakchi C, et al
    Performance of an Easy and Simple New Scoring Model in Predicting Multidrug-Resistant Enterobacteriaceae in Community-Acquired Urinary Tract Infections.
    Open Forum Infect Dis. 2019;6:ofz103.
    Abstract    

    Abstract available

  23. YODOSHI T, Matsushima M, Taniguchi T, Kinjo S, et al
    Utility of point-of-care Gram stain by physicians for urinary tract infection in children </=36 months.
    Medicine (Baltimore). 2019;98:e15101.
    Abstract    

    Abstract available

  24. SCHUH SK, Seidenberg R, Arampatzis S, Leichtle AB, et al
    Diagnosis of Urinary Tract Infections by Urine Flow Cytometry: Adjusted Cut-Off Values in Different Clinical Presentations.
    Dis Markers. 2019;2019:5853486.
    Abstract    

    Abstract available

  25. CRIVELLI JJ, Alhalabi F, Zimmern PE
    Electrofulguration in the advanced management of antibiotic-refractory recurrent urinary tract infections in women.
    Int J Urol. 2019 Apr 3. doi: 10.1111/iju.13963.
    Abstract    

    Abstract available

  26. SHAHEEN G, Akram M, Jabeen F, Ali Shah SM, et al
    Therapeutic Potential of Medicinal Plants for the Management of Urinary Tract Infection: A Systematic Review.
    Clin Exp Pharmacol Physiol. 2019 Apr 1. doi: 10.1111/1440-1681.13092.
    Abstract    

    Abstract available

  27. WILLIAMS G, Craig JC
    Long-term antibiotics for preventing recurrent urinary tract infection in children.
    Cochrane Database Syst Rev. 2019;4:CD001534.
    Abstract    

    Abstract available

  28. MARKOWITZ MA, Monti GK, Kim JH, Haake DA, et al
    Rapid diagnostic testing in the management of urinary tract infection: Potentials and limitations.
    Diagn Microbiol Infect Dis. 2019 Mar 5. pii: S0732-8893(19)30019.
    Abstract    

    Abstract available

  29. THURBER KM, Arnold JR, Narayanan PP, Dierkhising RA, et al
    Comparison of Intravenous and Oral Definitive Antibiotic Regimens in Hospitalized Patients with Gram-Negative Bacteremia from a Urinary Tract Infection.
    J Glob Antimicrob Resist. 2019 Mar 26. pii: S2213-7165(19)30082.
    Abstract    

    Abstract available

  30. SCHMITT K, Lehner C, Schuller S, Schupbach-Regula G, et al
    Antimicrobial use for selected diseases in cats in Switzerland.
    BMC Vet Res. 2019;15:94.
    Abstract    

    Abstract available

  31. SHEN BH, Bledsoe TA
    An Infectious Triple Play: Three Separate Infections in an Elderly Patient.
    R I Med J (2013). 2019;102:58-59.
    Abstract    

    Abstract available

  32. HOUMSOU RS, Wama BE, Agere H, Uniga JA, et al
    High Efficacy of Praziquantel in Schistosoma haematobium-Infected Children in Taraba State, Northeast Nigeria: A follow-up study.
    Sultan Qaboos Univ Med J. 2018;18:e304-e310.
    Abstract    

    Abstract available

  33. WRAGG R, Brownlee E, Robb A, Chandran H, et al
    The postnatal management of boys in a national cohort of bladder outlet obstruction.
    J Pediatr Surg. 2019;54:313-317.
    Abstract    

    Abstract available

  34. PANIAGUA-CONTRERAS GL, Monroy-Perez E, Bautista A, Reyes R, et al
    Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
    Pathog Glob Health. 2018;112:415-420.
    Abstract    

    Abstract available

  35. NILBERT M, Blackberg M, Ceberg J, Hagberg O, et al
    Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
    Scand J Urol. 2018;52:237-243.
    Abstract    

    Abstract available

  36. ALSAN M, Kammili N, Lakshmi J, Xing A, et al
    Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum beta-Lactamase-Producing Organisms, Hyderabad, India.
    Emerg Infect Dis. 2018;24:1490-1496.
    Abstract    

    Abstract available

  37. GANDASEGUI J, Fernandez-Soto P, Dacal E, Rodriguez E, et al
    Field and laboratory comparative evaluation of a LAMP assay for the diagnosis of urogenital schistosomiasis in Cubal, Central Angola.
    Trop Med Int Health. 2018 Jun 19. doi: 10.1111/tmi.13117.
    Abstract    

    Abstract available

  38. ABREU F, Rodriguez-Lucas C, Rodicio MR, Vela AI, et al
    Human Pasteurella multocida Infection with Likely Zoonotic Transmission from a Pet Dog, Spain.
    Emerg Infect Dis. 2018;24:1145-1146.
    Abstract    

    Abstract available

  39. LUND LC, Holzknecht BJ, Justesen US
    [Treatment of vancomycin-resistant enterococcal infections].
    Ugeskr Laeger. 2018;180.
    Abstract    

    Abstract available

  40. MORRIS L
    PURLs: An easy approach to obtaining clean-catch urine from infants.
    J Fam Pract. 2018;67:166-169.
    Abstract    

    Abstract available

  41. ZHAO D, Zhou Z, Hua X, Zhang H, et al
    Coexistence of mcr-1, blaKPC-2 and two copies of fosA3 in a clinical Escherichia coli strain isolated from urine.
    Infect Genet Evol. 2018;60:77-79.
    Abstract    

    Abstract available

  42. BOZKURT IH, Sefik E, Basmaci I, Yarimoglu S, et al
    RE: "Predictors for uroseptic shock in patients who undergo minimally invasive percutaneous nephrolithotomy".
    Urolithiasis. 2018;46:595-596.
    Abstract    



  43. ARMBRUSTER CE, Mobley HLT, Pearson MM
    Pathogenesis of Proteus mirabilis Infection.
    EcoSal Plus. 2018;8.
    Abstract    

    Abstract available

  44. WOOD T, Aarts MA, Okrainec A, Pearsall E, et al
    Emergency Room Visits and Readmissions Following Implementation of an Enhanced Recovery After Surgery (iERAS) Program.
    J Gastrointest Surg. 2018;22:259-266.
    Abstract    

    Abstract available

  45. EL SAYED I, Elkhwsky F, La Vecchia C, Alicandro G, et al
    The frequency of bladder cancer in Alexandria, Egypt, over the last two decades.
    Eur J Cancer Prev. 2017 May 19. doi: 10.1097/CEJ.0000000000000368.
    Abstract    



  46. CORIGLIANO A, Galasso O, Varano A, Riccelli DA, et al
    Urinary tract infections after early removal of urinary catheter in total joint arthroplasty.
    Eur Rev Med Pharmacol Sci. 2019;23.
    Abstract    

    Abstract available

  47. UDAONDO Z, Wongsurawat T, Jenjaroenpun P, Anderson C, et al
    Draft Genome Sequences of 48 Vancomycin-Resistant Enterococcus faecium Strains Isolated from Inpatients with Bacteremia and Urinary Tract Infection.
    Microbiol Resour Announc. 2019;8.
    Abstract    

    Abstract available

  48. YAZDI FT, Falah F, Vasiee A, Behbahani BA, et al
    Evaluation of adherence and anti-infective properties of probiotic Lactobacillus fermentum strain 4-17 against Escherichia coli causing urinary tract infection in humans.
    Microb Pathog. 2019 Apr 8. pii: S0882-4010(19)30538.
    Abstract    

    Abstract available

  49. WEESE JS, Blondeau J, Boothe D, Guardabassi LG, et al
    International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats.
    Vet J. 2019;247:8-25.
    Abstract    

    Abstract available

  50. SORENSEN TM, Holmslykke M, Nordlund M, Siersma V, et al
    Pre-test probability of urinary tract infection in dogs with clinical signs of lower urinary tract disease.
    Vet J. 2019;247:65-70.
    Abstract    

    Abstract available

  51. CHEN M, Wu Y, Yu S, Liu S, et al
    Drug Resistance and Integron Genes in Escherichia coli Isolated from Urinary Tract Infection.
    J Nanosci Nanotechnol. 2019;19:5989-5993.
    Abstract    

    Abstract available

  52. WILLIAMS G, Hodson EM, Craig JC
    Interventions for primary vesicoureteric reflux.
    Cochrane Database Syst Rev. 2019;2:CD001532.
    Abstract    

    Abstract available

  53. ORDONEZ M, Hwang EC, Borofsky M, Bakker CJ, et al
    Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi.
    Cochrane Database Syst Rev. 2019;2:CD012703.
    Abstract    

    Abstract available

  54. PAEZ-CANRO C, Alzate JP, Gonzalez LM, Rubio-Romero JA, et al
    Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.
    Cochrane Database Syst Rev. 2019;1:CD010871.
    Abstract    

    Abstract available

  55. ONZO-ABOKI A, Ibikounle M, Boko PM, Savassi BS, et al
    Human schistosomiasis in Benin: Countrywide evidence of Schistosoma haematobium predominance.
    Acta Trop. 2019;191:185-197.
    Abstract    

    Abstract available

  56. KALAITZIDOU I, Ladomenou F, Athanasopoulos E, Anatoliotaki M, et al
    Susceptibility patterns of uropathogens identified in hospitalized children.
    Pediatr Int. 2019;61:246-251.
    Abstract    

    Abstract available

  57. TORZEWSKA A, Bednarska K, Rozalski A
    Influence of various uropathogens on crystallization of urine mineral components caused by Proteus mirabilis.
    Res Microbiol. 2019;170:80-85.
    Abstract    

    Abstract available

  58. MIOTLA P, Wawrysiuk S, Naber K, Markut-Miotla E, et al
    Should We Always Use Antibiotics after Urodynamic Studies in High-Risk Patients?
    Biomed Res Int. 2018;2018:1607425.
    Abstract    

    Abstract available

  59. MARZUILLO P, Guarino S, Esposito T, Campana G, et al
    Antibiotics for urethral catheterization in children undergoing cystography: retrospective evaluation of a single-center cohort of pediatric non-toilet-trained patients.
    Eur J Pediatr. 2019;178:423-425.
    Abstract    

    Abstract available

  60. JANKOWSKI RJ, Tu LM, Carlson C, Robert M, et al
    A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence.
    Int Urol Nephrol. 2018;50:2153-2165.
    Abstract    

    Abstract available

  61. ALFAKEEKH K, Azar M, Sowailmi BA, Alsulaiman S, et al
    Immunosuppressive burden and risk factors of infection in primary childhood nephrotic syndrome.
    J Infect Public Health. 2019;12:90-94.
    Abstract    

    Abstract available

  62. SANTE L, Aguirre-Jaime A, Miguel MA, Ramos MJ, et al
    Epidemiological study of secondary bloodstream infections: The forgotten issue.
    J Infect Public Health. 2019;12:37-42.
    Abstract    

    Abstract available

  63. ACIERNO MJ, Partyka M, Waite K, da Cunha A, et al
    Effect of refrigeration of clinical canine urine samples on quantitative bacterial culture.
    J Am Vet Med Assoc. 2018;253:177-180.
    Abstract    

    Abstract available

  64. LIPOVY B, Holoubek J, Hanslianova M, Cvanova M, et al
    Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications.
    Burns. 2018;44:1561-1572.
    Abstract    

    Abstract available

  65. LIPOVY B, Holoubek J, Hanslianova M, Cvanova M, et al
    Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: Epidemiology and general microbiological characteristics.
    Burns. 2018;44:1551-1560.
    Abstract    

    Abstract available

  66. GOLUBOVSKY JL, Ilyas H, Chen J, Tanenbaum JE, et al
    Risk factors and associated complications for postoperative urinary retention after lumbar surgery for lumbar spinal stenosis.
    Spine J. 2018;18:1533-1539.
    Abstract    

    Abstract available

  67. JAIN D, Berven SH, Carter J, Zhang AL, et al
    Bariatric surgery before elective posterior lumbar fusion is associated with reduced medical complications and infection.
    Spine J. 2018;18:1526-1532.
    Abstract    

    Abstract available

  68. GREENE DJ, Gill BC, Hinck B, Nyame YA, et al
    American Urological Association Antibiotic Best Practice Statement and Ureteroscopy: Does Antibiotic Stewardship Help?
    J Endourol. 2018;32:283-288.
    Abstract    

    Abstract available

  69. SUI W, Lipsky MJ, Matulay JT, Robins DJ, et al
    Timing and Predictors of Early Urologic and Infectious Complications After Renal Transplant: An Analysis of a New York Statewide Database.
    Exp Clin Transplant. 2018;16:665-670.
    Abstract    

    Abstract available

  70. DE NISCO NJ, Neugent M, Mull J, Chen L, et al
    Direct Detection of Tissue-Resident Bacteria and Chronic Inflammation in the Bladder Wall of Postmenopausal Women with Recurrent Urinary Tract Infection.
    J Mol Biol. 2019 Apr 16. pii: S0022-2836(19)30202.
    Abstract    

    Abstract available

  71. NALLIAH S, Fong JSH, Yi Thor AY, Lim OH, et al
    The use of chemotherapeutic agents as prophylaxis for recurrent urinary tract infection in healthy nonpregnant women: A network meta-analysis.
    Indian J Urol. 2019;35:147-155.
    Abstract    

    Abstract available

  72. LIANG CC, Huang TJ, Yang SH, Su JY, et al
    Prevention of catheter-associated urinary tract infection in neurological post-operation patients: a best practice implementation project.
    JBI Database System Rev Implement Rep. 2019.
    Abstract    

    Abstract available

  73. BEHZADI P, Behzadi E, Pawlak-Adamska EA
    Urinary tract infections (UTIs) or genital tract infections (GTIs)? It's the diagnostics that count.
    GMS Hyg Infect Control. 2019;14:Doc14.
    Abstract    

    Abstract available

  74. BROWN C, McLeod D, Ching C
    Knowledge of vesicoureteral reflux obtained by screening voiding cystourethrogram in children with multicystic dysplastic kidney does not change patient management or prevent febrile urinary tract infection.
    J Pediatr Urol. 2019 Mar 22. pii: S1477-5131(19)30072.
    Abstract    

    Abstract available

  75. WADE D, Cooper J, Derry F, Taylor J, et al
    Uro-Vaxom(R) versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study.
    Trials. 2019;20:223.
    Abstract    

    Abstract available

  76. SITTHISARUNKUL N, Uthairat M, Dissaneewate P, McNeil E, et al
    Characteristics and Findings of Childhood Urinary Tract Infection in the Last Decade.
    Urol Int. 2019 Apr 16:1-6. doi: 10.1159/000497443.
    Abstract    

    Abstract available

  77. M Y, Chawla K, Bankapur A, Acharya M, et al
    A micro-Raman and chemometric study of urinary tract infection-causing bacterial pathogens in mixed cultures.
    Anal Bioanal Chem. 2019 Apr 15. pii: 10.1007/s00216-019-01784.
    Abstract    

    Abstract available

  78. LAAN BJ, Geerlings SE
    Non-antibiotic prevention strategies against catheter-associated urinary tract infections.
    Lancet Infect Dis. 2019 Apr 12. pii: S1473-3099(18)30758.
    Abstract    



  79. FASUGBA O, Cheng AC, Gregory V, Graves N, et al
    Chlorhexidine for meatal cleaning in reducing catheter-associated urinary tract infections: a multicentre stepped-wedge randomised controlled trial.
    Lancet Infect Dis. 2019 Apr 12. pii: S1473-3099(18)30736.
    Abstract    

    Abstract available

  80. REEDER B, Drake C, Ozkaynak M, Wald HL, et al
    Usability Testing of a Mobile Clinical Decision Support App for Urinary Tract Infection Diagnosis in Nursing Homes.
    J Gerontol Nurs. 2019 Apr 12:1-7. doi: 10.3928/00989134-20190408.
    Abstract    

    Abstract available

  81. LEIHOF RF, Ethelberg S, Nielsen KL, Rasmussen SC, et al
    Nosocomial urinary tract infection and risk of bacteraemia in elderly patients: urinary catheter, clinical factors and bacterial species.
    Infect Dis (Lond). 2019 Apr 15:1-3. doi: 10.1080/23744235.2019.1599135.
    Abstract    



  82. SCHILLING I, Behrens H, Hugenschmidt C, Liedtke J, et al
    Patient involvement in clinical trials: motivation and expectations differ between patients and researchers involved in a trial on urinary tract infections.
    Res Involv Engagem. 2019;5:15.
    Abstract    

    Abstract available

  83. AHMED SS, Shariq A, Alsalloom AA, Babikir IH, et al
    Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections.
    Int J Health Sci (Qassim). 2019;13:48-55.
    Abstract    

    Abstract available

  84. ARAJ GF, Taleb R, El Beayni NK, Goksu E, et al
    Vibrio albensis: An unusual urinary tract infection in a healthy male.
    J Infect Public Health. 2019 Apr 10. pii: S1876-0341(19)30127.
    Abstract    

    Abstract available

  85. CHARLIER C, Dang J, Woerther PL
    [In-hospital management of acute complicated urinary tract infections].
    Nephrol Ther. 2019;15 Suppl 1:S27-S32.
    Abstract    

    Abstract available

  86. BUHMANN MT, Abt D, Nolte O, Neu TR, et al
    Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load.
    Microbiome. 2019;7:60.
    Abstract    

    Abstract available

  87. PINEIRO PEREZ R, Cilleruelo Ortega MJ, Ares Alvarez J, Baquero-Artigao F, et al
    [Recommendations on the diagnosis and treatment of urinary tract infection].
    An Pediatr (Barc). 2019 Apr 10. pii: S1695-4033(19)30138.
    Abstract    

    Abstract available

  88. ARANA DM, Sanchez A, Bautista V, Oteo-Iglesias J, et al
    ESBL-producing-multidrug resistant E. coli population from urinary tract infections is less diverse than non-ESBL-multidrug resistant population.
    Enferm Infecc Microbiol Clin. 2019 Apr 9. pii: S0213-005X(19)30144.
    Abstract    

    Abstract available


  89. Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment.
    Ont Health Technol Assess Ser. 2019;19:1-153.
    Abstract    

    Abstract available

  90. CHISANGO TJ, Ndlovu B, Vengesai A, Nhidza AF, et al
    Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    BMC Infect Dis. 2019;19:219.
    Abstract    

    Abstract available

  91. RUMI MV, Mas J, Elena A, Cerdeira L, et al
    Co-occurrence of clinically relevant beta-lactamases and MCR-1 encoding genes in Escherichia coli from companion animals in Argentina.
    Vet Microbiol. 2019;230:228-234.
    Abstract    

    Abstract available

  92. BARDIA A, Wai M, Fontes ML
    Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications.
    Curr Opin Anaesthesiol. 2019;32:80-85.
    Abstract    

    Abstract available

  93. MULLER-WIELAND D, Kellerer M, Cypryk K, Skripova D, et al
    Efficacy and Safety of Dapagliflozin or Dapagliflozin Plus Saxagliptin Versus Glimepiride as Add-on to Metformin in Patients With Type 2 Diabetes.
    Diabetes Obes Metab. 2018 Jun 27. doi: 10.1111/dom.13437.
    Abstract    

    Abstract available

  94. BRITT NS, Ritchie DJ, Kollef MH, Burnham CD, et al
    Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02400.
    Abstract    

    Abstract available

  95. ZHANG Y, Wang Q, Yin Y, Chen H, et al
    Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from China CRE Network.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01882.
    Abstract    

    Abstract available

  96. WEISS WJ, Pulse ME, Nguyen P, Peterson K, et al
    Activity of Meropenem-Vaborbactam Against Carbapenem-resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01439.
    Abstract    

    Abstract available

  97. DUMITRASCU A, Senn L, Rothuizen LE, Rodondi PY, et al
    [Acute respiratory and urinary tract infections in medical practice : a selection of complementary medicines].
    Rev Med Suisse. 2019;15:875-881.
    Abstract    

    Abstract available

  98. LUGG-WIDGER FV, Angel L, Cannings-John R, Jones H, et al
    Long-term outcomes of urinary tract infection (UTI) in Childhood (LUCI): protocol for an electronic record-linked cohort study.
    BMJ Open. 2019;9:e024210.
    Abstract    

    Abstract available

  99. XU J, He F
    Genomic analysis of two strains co-isolated from a urinary tract infection: NDM-1 producing Enterobacter cloacae accompanied with ESBL producing Escherichia coli.
    J Glob Antimicrob Resist. 2019 Apr 18. pii: S2213-7165(19)30096.
    Abstract    

    Abstract available

  100. HOTEZ PJ, Harrison W, Fenwick A, Bustinduy AL, et al
    Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.
    PLoS Negl Trop Dis. 2019;13:e0007025.
    Abstract    



  101. KUKULA VA, MacPherson EE, Tsey IH, Stothard JR, et al
    A major hurdle in the elimination of urogenital schistosomiasis revealed: Identifying key gaps in knowledge and understanding of female genital schistosomiasis within communities and local health workers.
    PLoS Negl Trop Dis. 2019;13:e0007207.
    Abstract    

    Abstract available

  102. TIAN-BI YT, Webster B, Konan CK, Allan F, et al
    Molecular characterization and distribution of Schistosoma cercariae collected from naturally infected bulinid snails in northern and central Cote d'Ivoire.
    Parasit Vectors. 2019;12:117.
    Abstract    

    Abstract available

  103. BELFIELD K, Kalith S, Aimar K, Parkinson R, et al
    Micro-organisms attached to the lumens and balloons of indwelling urinary catheters and correlation with symptoms, antibiotic use and catheter specimen of urine results.
    J Med Microbiol. 2019;68:549-554.
    Abstract    

    Abstract available

  104. SOGAARD KK, Veres K, Norgaard M, Djurhuus JC, et al
    Pyelonephritis in persons after age 50 as a clinical marker of urogenital cancer.
    Clin Microbiol Infect. 2019;25:87-91.
    Abstract    

    Abstract available

  105. YANG B, Foley S
    Urinary tract infection vaccines - the 'burning' issue.
    BJU Int. 2019;123:743-744.
    Abstract    



  106. HAY AD
    Antibiotic prescribing in primary care.
    BMJ. 2019;364:l780.
    Abstract    



  107. KMIETOWICZ Z
    SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation.
    BMJ. 2018;363:k4828.
    Abstract    



  108. LEE AS, Bowen DK, Vatsky S, Zderic SA, et al
    Percutaneous nephrolithotomy in an 8-week-old infant.
    Can J Urol. 2018;25:9363-9365.
    Abstract    

    Abstract available

  109. PENNINGTON LF, Alouffi A, Mbanefo EC, Ray D, et al
    H-IPSE is a pathogen-secreted host nucleus infiltrating protein (infiltrin) expressed exclusively by the Schistosoma haematobium egg stage.
    Infect Immun. 2017 Sep 18. pii: IAI.00301-17. doi: 10.1128/IAI.00301.
    Abstract    

    Abstract available

  110. ZHONG H, Zhao XY, Zhang ZL, Gu ZC, et al
    Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;52:443-450.
    Abstract    

    Abstract available

  111. MISHRA K, Gupta P
    50 Years Ago in The Journal of Pediatrics: Detection of Bacteriuria in Children.
    J Pediatr. 2019;204:58.
    Abstract    



  112. RAMGOPAL S, Janofsky S, Zuckerbraun NS, Ramilo O, et al
    Risk of Serious Bacterial Infection in Infants Aged </=60 Days Presenting to Emergency Departments with a History of Fever Only.
    J Pediatr. 2018 Oct 2. pii: S0022-3476(18)31217.
    Abstract    

    Abstract available

  113. SCHAEFFER EM
    Re: Effect of a Hospital-Associated Urinary Tract Infection Reduction Policy on General Surgery Patients.
    J Urol. 2019 Mar 29:101097JU0000000000000254. doi: 10.1097/JU.0000000000000254.
    Abstract    



  114. NICKEL JC
    Editorial Comment.
    J Urol. 2019;201:555.
    Abstract    



  115. GRIEBLING TL
    Re: Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-Analysis by the European Association of Urology Urological Infection Guidelines Panel.
    J Urol. 2018;200:677.
    Abstract    



  116. WANG DS
    Re: Impact of Foley Catheter Placement by Medical Students on Rates of Postoperative Urinary Tract Infection.
    J Urol. 2019 Apr 25:101097JU0000000000000308. doi: 10.1097/JU.0000000000000308.
    Abstract    



  117. SCHAEFFER EM
    Re: Continuous Low-Dose Antibiotic Prophylaxis for Adults with Repeated Urinary Tract Infections (AnTIC): A Randomised, Open-Label Trial.
    J Urol. 2019 Apr 25:101097JU0000000000000302. doi: 10.1097/JU.0000000000000302.
    Abstract    



  118. KEENE S, Murthy K, Pallotto E, Brozanski B, et al
    Acquired Infection and Antimicrobial Utilization During Initial NICU Hospitalization in Infants with Congenital Diaphragmatic Hernia.
    Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001835.
    Abstract    

    Abstract available

  119. KORNFALT ISBERG H, Hedin K, Melander E, Molstad S, et al
    Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study.
    PLoS One. 2019;14:e0214572.
    Abstract    

    Abstract available

  120. WU X, Li Z, Cao J, Jiao J, et al
    The association between major complications of immobility during hospitalization and quality of life among bedridden patients: A 3 month prospective multi-center study.
    PLoS One. 2018;13:e0205729.
    Abstract    

    Abstract available

  121. PHILLIPS S, Robbins A, Loader J, Hanger J, et al
    Chlamydia pecorum gastrointestinal tract infection associations with urogenital tract infections in the koala (Phascolarctos cinereus).
    PLoS One. 2018;13:e0206471.
    Abstract    

    Abstract available

  122. TANDOGDU Z, Kakariadis ETA, Naber K, Wagenlehner F, et al
    Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study.
    PLoS One. 2019;14:e0214710.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Urinary Tract Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;